Figures & data
![](/cms/asset/9ff7a18b-6fc9-45e5-bbfa-b96096fcbfd8/dddt_a_12298379_uf0001_c.jpg)
Table 1 Pharmacological Activities of PTL in Tumors (Since 2019)
Figure 2 Selected signaling pathways regulated by PTL. The key components and signal transduction cascade reactions in NF-κB signaling, Wnt/β-catenin signaling, JAK/STAT signaling, FAK1 signaling, and p53 signaling were depicted, and the nodes targeted by PTL were labeled.
![Figure 2 Selected signaling pathways regulated by PTL. The key components and signal transduction cascade reactions in NF-κB signaling, Wnt/β-catenin signaling, JAK/STAT signaling, FAK1 signaling, and p53 signaling were depicted, and the nodes targeted by PTL were labeled.](/cms/asset/7ea4c76e-5ec6-4baa-b3a4-1238a32add3b/dddt_a_12298379_f0002_c.jpg)
Figure 3 Pivotal cellular processes affected by PTL. Schematic diagram showing the formation of microtentacle and major antioxidant machineries were plotted. The targets regulated by PTL were marked.
![Figure 3 Pivotal cellular processes affected by PTL. Schematic diagram showing the formation of microtentacle and major antioxidant machineries were plotted. The targets regulated by PTL were marked.](/cms/asset/554e54c5-097c-438c-a2cb-6159e32884a5/dddt_a_12298379_f0003_c.jpg)
Table 2 Unmodified Nanoparticles Solely Incorporated with PTL
Table 3 Undecorated Nanovectors Encapsulated PTL and Other Agents
Table 4 Targeted Nanocarriers Encapsulated PTL with or without Other Agents